Call for Abstract
Scientific Program
15th Annual Congress on Pharmacology and Toxicology , will be organized around the theme “Sights and Insights into Pharmacology and Toxicology”
Euro Pharmacology 2018 is comprised of 14 tracks and 227 sessions designed to offer comprehensive sessions that address current issues in Euro Pharmacology 2018.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Pharmacology can be defined as the application of systems biology principles to the field of pharmacology. It seeks to understand how drugs affect the human body as a single complex biological system. Instead of considering the effect of a drug to be the result of one specific drug-protein interaction, systems pharmacology considers the effect of a drug to be the outcome of the network of interactions a drug may have.
- Track 1-1Cardiovascular pharmacology
- Track 1-2Immunopharmacology
- Track 1-3Respiratory pharmacology
- Track 1-4Gastropharmacology
- Track 1-5Chemical-protein interactions
- Track 1-6Protein–protein interactions
- Track 1-7genetic interactions
- Track 1-8Physiological interactions with biological systems
- Track 1-9Pharmacogenetics in clinical practice
- Track 1-10Molecular studies and genomic analysis
Toxicology is a branch of science that deals with poisons and their effect on the living organisms. A poison can be defined as any substance that causes a harmful effect when administered, either by accident or design, to a living organism. Toxicology also includes the study of harmful effects which are the cause of various kinds of physical phenomena, such as radiation and noise.
- Track 2-1Drug and Chemical Toxicology
- Track 2-2Computerized modeling
- Track 2-3Descriptive and Mechanistic toxicology
- Track 2-4Analytical toxicology
- Track 2-5Environmental toxicology
- Track 2-6Economic Toxicology
- Track 2-7Exploratory & Discovery Toxicology
- Track 2-8Organ Toxicity
- Track 2-9Predictive Toxicology
- Track 2-10Systems toxicology
- Track 2-11Comprehensive Toxicology
- Track 2-12Medical toxicology
- Track 2-13Pediatric and Geriatric Toxicology
- Track 2-14Molecular & cellular toxicology
- Track 2-15Food & nutritional toxicology
- Track 2-16Nanotoxicology
- Track 2-17Human genetic toxicology
- Track 2-18Immunotoxicology
- Track 2-19Systemic toxicology
- Track 2-20Inhalation toxicology
- Track 2-21Computational toxicology
- Track 2-22Clinical toxicology
Ethnopharmacology is the study of medicinally used substances, especially folk remedies, by diverse cultural or ethnic groups. Traditional medicine is a term applied to pre-scientific medical systems that possess bodies of medical knowledge, including pharmacopoeia, that are passed through generations from healer to healer. The combined use of vaccines and immunostimulants is emerging as one of the innovative approaches in adjuvant development. The role of herbal drugs as immunomodulator agents are well-documented and their importance in bioprospecting is obvious.
- Track 3-1Herbal drug industry
- Track 3-2Medicinal plant use
- Track 3-3Ethnopharmacology of medicinal plants
- Track 3-4 Traditional medicine
- Track 3-5Extraction and isolation procedures
- Track 3-6Phytochemicals research
- Track 3-7Development of new drugs against severe illeness
Neuropharmacology is the study of drugs that alter processes controlled by the nervous system. Molecular neuropharmacology involves the study of neurons and their neurochemical interactions, with the overall goal of developing drugs that have beneficial effects on neurological function. Neuropharmacology is merely concerned with neuromodulators, enzymes, second messengers, co-transporters, ion channels, neurotransmitters, neuropeptides, neurohormones, receptor proteins and their interactions in the central and peripheral nervous systems.
Psychopharmacology is the branch of pharmacology dealing with the study of the actions and the effects of psychoactive drugs. Psychopharmacology is an interdisciplinary field combining psychology with pharmacology and dealing largely with psychotropic drugs, neurohormones, and, neurotransmitters.
- Track 4-1Neurochemical interactions
- Track 4-2Molecular neuropharmacology
- Track 4-3Behavioural neuropharmacology
- Track 4-4Targets of drug action in CNS
- Track 4-5Drugs acting on chemical signaling
- Track 4-6Psychopharmacological substances and physchopharmacological research
- Track 4-7Neuropsychopharmacology
- Track 4-8Dose response relation in psychiatric medicine
- Track 4-9Psychotherapy and innovative psychological approaches
Molecular pharmacology is a field of pharmacology. The branch of pharmacology is concerned with the study of molecular basis of pharmacology. Molecular pharmacologists study the molecular study of pharmaceuticals and natural compounds used in the treatment of disease, and they also study disease on a molecular basis with the goal of developing pharmacologically active agents which could be used in the treatment of disease.
Clinical pharmacology is a medical discipline and branch of pharmacology which, on a scientific basis, combines clinical expertise and pharmacology with the goal of improving efficacy and safety in the clinical use of drugs. The significant role of drug therapy in many fields of medicine is the background for establishing clinical pharmacology as a separate discipline.
- Track 5-1ADME of drugs
- Track 5-2Rational Prescribing
- Track 5-3Adverse drug effects
- Track 5-4Drug interactions
- Track 5-5Drug Development
- Track 5-6Pharmacogenomics
- Track 5-7Structure-guided drug design
- Track 5-8Molecular cloning of drug targets
- Track 5-9Cellular basis of pharmacokinetics
- Track 5-10Receptors and modulation of their response
- Track 5-11Drug–receptor interactions
- Track 5-12G-Protein-coupled receptors
- Track 5-13Pharmacology of transcription
- Track 5-14Intercellular communication
- Track 5-15Pharmacology of defence process
Nursing Pharmacology is the study of how guidelines for nurses about the substances that interact with living organisms to produce a change in function. It deals with the research, discovery, and characterization of chemicals which show biological effects and the illumination of cellular and organism function in relation to these chemicals.
- Track 6-1Geriatric pharmacology
- Track 6-2Endocrine pharmacology
- Track 6-3Pediatric pharmacology
- Track 6-4Pharmacology management of asthama
- Track 6-5Core drugs in anaesthetic practice
- Track 6-6Cardiovascular drugs
- Track 6-7Central nervous system drugs
- Track 6-8Antiemetics and related drugs
- Track 6-9Other important drugs
- Track 6-10Anesthetics doses and routes of administration
- Track 6-11Adverse reactions, precautions and interactions of anesthetics
Environmental pharmacology which can be defined as the effect of pharmaceuticals and house care products on the environment and the ecosystem. Environmental pharmacology is a relatively new and emerging specialty of pharmacology. It involves the study of gene-environment interaction, drug-environment interaction and toxin-environment interaction.
- Track 7-1Source & fate of pharmaceutical products
- Track 7-2Source & fate of household products
- Track 7-3Effect of xenobiotics on environment & ecosystem
- Track 7-4Toxin-environment interaction
- Track 7-5Miscellaneous toxicity
- Track 7-6Gene environment interaction
- Track 7-7Pharmaceutical disposal-environment standards
- Track 7-8Environmental ethics and guidelines- safe disposal
- Track 7-9Environmental risk assessment
- Track 7-10Environmental classification of drugs
Genetic toxicology helps to discern the possibility of heritable mutations, developmental defects, cancer initiation, aging, and other long-term adverse genetic effects. Genotoxicity describes the assets of chemical sellers that damage the genetic records inside cellular causing mutations, which may lead to most cancers. At the same time, genotoxicity is often stressed with mutagenicity; all mutagens are genotoxic, while no longer all genotoxic materials are mutagenic. The alteration could have direct or indirect consequences at the DNA: the induction of mutations mistimed occasion activation, and direct DNA damage leading to mutations.
- Track 8-1Predicting drug-drug interactions
- Track 8-2Exogenous& endogenous factors of drug response
- Track 8-3Genomic basis of pharmacogenetics
- Track 8-4harmacogentic study designs & considerations
- Track 8-5Pharmacogenetic phenotypes
- Track 8-6Pharmacogenomics in personalized therapuetics
- Track 8-7Drug devolpment, metabolism
- Track 8-8Biomarkers
- Track 8-9Cancer-therapy-monoclonal antibodies
- Track 8-10Personalized medicine
- Track 8-11Drug metabolizing enzymes
- Track 8-12Pharmacogenomics applications in drug development
- Track 8-13Theragnostics
- Track 8-14Polypharmacy
Reverse pharmacology includes drug screening deals with reverse pharmacology and forward pharmacology are two approaches to drug discovery. Target based drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology, screening of chemical libraries and its pharmacology, methods to determine biological targeting, by systematically perturbing and interrogating biological pathways with synthetically novel chemical tools, preclinical validation of target biology is beginning to illuminate a more cost-effective and efficient paradigm for the development of novel drugs modulating novel targets.
- Track 9-1Individual case safety report
- Track 9-2Coding of adverse events
- Track 9-3Seriousness determination
- Track 9-4Expedited & clinical trial reporting
- Track 9-5Spontaneous reporting
- Track 9-6Aggregate reporting & other reporting methods
Cardio pharmacodynamics of digitalis is most frequently used to increase the adequacy of the circulation in patients with CCF and to slow the ventricular rate in patients with atrial fibrillation or flutter NB: the main action of digitalis is its ability to increase myocardial contractility its positive isotropic action results in, a. increased cardiac output, b. decreased heart size, c. decreased venous pressure, d. decreased circulating blood volume. e. neural tissue being responsible for indirect cardiac actions of the drug finally, changes to the circulation brought about by digitalis frequently result in reflex autonomic & hormonal changes which affect the CVS.
- Track 10-1Selection, design of safety pharmacological studies
- Track 10-2Pre-Clinical safety pharmacology & evaluation
- Track 10-3Core Battery Organ Systems & studies
- Track 10-4General safety assays
- Track 10-5Screening assays
- Track 10-6Frontloading
- Track 10-7Alternate Models
- Track 10-8Integrated core battery assessment
- Track 10-9Integrating safety pharmacology end points
- Track 10-10Transistional safety pharmacology
Forensic toxicology uses toxicology and other disciplines such as analytical chemistry, clinical chemistry and pharmacology to aid medical or legal investigation of drug use, poisoning and death. It deals with the investigation of toxic substances, poisonous products and environmental chemicals.
- Track 11-1Â Environmental data on medicinal products
- Track 11-2Tracking data on environmental exposure
- Track 11-3Environmental risk management plans
- Track 11-4Risk identification, promotion of environmental monitoring
- Track 11-5Global perspective on ecopharmacovigilance issues
- Track 11-6After product launch risks and effects
Food and Chemical Toxicology (FCT), an internationally renowned journal, that publishes original research articles and reviews on toxic effects, in animals and humans, of natural or synthetic chemicals occurring in the human environment with particular emphasis on food, drugs and chemicals, including agricultural and industrial safety, and consumer product safety. Areas such as safety evaluation of novel foods and ingredients, biotechnologically-derived products and nanomaterials are included in the scope of the journal. FCT also encourages submission of papers on inter-relationships between nutrition and toxicology and on in vitro techniques.
- Track 12-1Drug monitoring
- Track 12-2Pharmaceutical preparations - adverse reactions
- Track 12-3Product survelliance
- Track 12-4Postmarketing legislation
- Track 12-5Medication errors
- Track 12-6substandard medicines
- Track 12-7Study of drug related deaths
- Track 12-8Abuse and misuse of medicines
- Track 12-9Adverse affects of medicines with chemicals other medicines & food
- Track 12-10Case reports of acute & chronic poisoning
- Track 12-11Specific patient populations & drug safety
- Track 12-12Minimizing drug side effects
Pharmacological Testing includes both Pharmacologic stress testing and nuclear stress test. Whereas the Pharmacologic stress testing is the set up after activity testing, is an analytic system in which cardiovascular anxiety affected by pharmacologic operators is shown in patients with diminished useful limit or in patients who can't work out. And Pharmacological nuclear stress test is a demonstrative test used to assess blood stream to the heart. Amid the test, a little measure of radioactive tracer is infused into a vein. A unique camera, called a gamma camera, identifies the radiation discharged by the tracer to create PC pictures of the heart.
- Track 13-1Pharmacokinetics/ PBPK modeling
- Track 13-2Disease models
- Track 13-3Inhalation toxicology
- Track 13-4Systems biology studies
- Track 13-5Bioinformatics
- Track 13-6Data integration
- Track 13-7Biomarker development
Pharmaceutical chemists are involved in the development and assessment of therapeutic compounds. Pharmaceutical chemistry encompasses drug design, drug synthesis, and the evaluation of drug efficacy (how effective it is in treating a condition) and drug safety. Drug discovery is the core of pharmaceutical chemistry. The drug discovery process includes all the stages of drug development, from targeting a disease or medical condition to toxicity studies in animals, or even, by some definitions, testing the drug on human subjects. Typically, conditions that affect a larger percentage of the population receive more attention and more research funding.
- Track 14-1Drug design stratagies
- Track 14-2Biotechnology & drug discovery
- Track 14-3Drug metabolism
- Track 14-4Chemisty of acids and bases
- Track 14-5Volumetric analysis of drugs
- Track 14-6All classes of drugs SAR, action
- Track 14-7Stability of drugs and medicines
- Track 14-8Steriochemistry
- Track 14-9Physiochemical properties of drugs
- Track 14-10Chromatographic methods for analysis
- Track 14-11Rational drug development
- Track 14-12CADD, SBDD, LBDD, in silico drug design
- Track 14-13 Lead Optimization
- Track 14-14Clinical Evaluation